Karah Herdman Parschauer
Karah Herdman Parschauer's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price…
Insider buying and selling since 2018
Karah Herdman Parschauer has no open-market purchase on record since 2018 across 2 companies. Sales in each of the last 8 years.
Karah Herdman Parschauer reported 0 open-market purchases and 33 sales since 2018; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 5×5 trades |
| 2024 | — | 3×3 trades |
| 2023 | — | 2×2 trades |
| 2022 | — | 2×2 trades |
| 2021 | — | 5×5 trades |
| 2020 | — | 9×9 trades |
| 2019 | — | 4×4 trades |
| 2018 | — | 3×3 trades |
Insider at 2 companies
- Ultragenyx Pharmaceutical RARE2018–2025 · 0 purchases, 31 sales
- Evolus EOLS2024–2025 · 0 purchases, 2 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Karah Herdman Parschauer's trades
Has Karah Herdman Parschauer bought shares on the open market?
Karah Herdman Parschauer has no open-market purchase on record since 2018 across 2 companies. Sales in each of the last 8 years.
When did Karah Herdman Parschauer last buy or sell shares?
In SEC filings since 2018: no open-market purchase is on record; the latest open-market sale is from 2025.
Which companies has Karah Herdman Parschauer traded as an insider?
2 companies: Ultragenyx Pharmaceutical (RARE, 2018–2025), Evolus (EOLS, 2024–2025).